Bariatric Surgery and Inflammatory Bowel Disease: National Trends and Outcomes Associated with Procedural Sleeve Gastrectomy vs Historical Bariatric Surgery Among US Hospitalized Patients 2009–2020
Open Access
- 7 October 2023
- journal article
- research article
- Published by Springer Nature in Obesity Surgery
- Vol. 33 (11) , 3472-3486
Abstract
Purpose: The association between bariatric surgery and IBD-related inpatient outcomes is not well characterized. We report, analyze, and compare inpatient trends and outcomes among encounters with a history of bariatric surgery (Hx-MBS) compared to those receiving bariatric surgery during index admission (PR-MBS) admitted from 2009 to 2020. Methods: Retrospective cohort design: the 2009–2020 National Inpatient Sample (NIS) databases were used to identify hospital encounters with patients aged ≥ 18 years with a history of MBS (Hx-MBS) or with procedure coding indicating MBS procedure (PR-MBS) according to International Classification of Diseases, Ninth (ICD-9-CM/ ICD-9-PCS) or Tenth Revision (ICD-10-CM/ICD-10-PCS) Clinical Modification/Procedure Coding System during index admission (ICD-9-CM: V4586; ICD-10-CM: Z9884; ICD-9-PR: 4382, 4389; ICD-10-PR: 0DB64Z3, 0DB63ZZ). Pearson χ2 analysis, analysis of variance, multivariable regression analyses, and propensity matching on independent variables were conducted to analyze significant associations between variables and for primary outcome inflammatory bowel disease-related admission, and secondary outcomes: diagnosis of nonalcoholic steatohepatitis, nonalcoholic fatty liver disease, or chronic mesenteric ischemia during admission. Results: We identified 3,365,784 (76.20%) Hx-MBS hospitalizations and 1,050,900 hospitalizations with PR-MBS (23.80%). Propensity score matching analysis demonstrated significantly higher odds of inflammatory bowel disease, and chronic mesenteric ischemia for Hx-MBS compared to PR-MBS, and significantly lower odds of nonalcoholic steatohepatitis and nonalcoholic fatty liver disease for Hx-MBS compared to PR-MBS. Conclusion: In our study, Hx-MBS was associated with significantly increased odds of inflammatory bowel disease and other GI pathologies compared to matched controls. The mechanism by which this occurs is unclear. Additional studies are needed to examine these findings. GraphicalKeywords
This publication has 96 references indexed in Scilit:
- Reprogramming of Intestinal Glucose Metabolism and Glycemic Control in Rats After Gastric BypassScience, 2013
- Metabolic and Hormonal Changes After Laparoscopic Roux-en-Y Gastric Bypass and Sleeve Gastrectomy: a Randomized, Prospective TrialObesity Surgery, 2012
- Intestinal adaptation after ileal interposition surgery increases bile acid recycling and protects against obesity-related comorbiditiesAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2010
- Vitamin B12 in Health and DiseaseNutrients, 2010
- Peyer's Patches: The Immune Sensors of the IntestineInternational Journal of Inflammation, 2010
- Ibuprofen and other widely used non-steroidal anti-inflammatory drugs inhibit antibody production in human cellsCellular Immunology, 2009
- Bacterial-mucosal interactions in inflammatory bowel disease—an alliance gone badAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2008
- Novel role of the vitamin D receptor in maintaining the integrity of the intestinal mucosal barrierAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2008
- Culture-Independent Analyses of Temporal Variation of the Dominant Fecal Microbiota and Targeted Bacterial Subgroups in Crohn's DiseaseJournal of Clinical Microbiology, 2006
- Gastrointestinal Adaptation Following Small Bowel Bypass for ObesityAnnals of Surgery, 1977